Galmed Pharmaceuticals Stock Price History
| GLMD Stock | USD 2.94 0.08 2.80% |
Below is the normalized historical share price chart for Galmed Pharmaceuticals extending back to March 13, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Galmed Pharmaceuticals stands at 2.94, as last reported on the 3rd of December, with the highest price reaching 3.10 and the lowest price hitting 2.75 during the day.
If you're considering investing in Galmed Stock, it is important to understand the factors that can impact its price. Galmed Pharmaceuticals is out of control given 3 months investment horizon. Galmed Pharmaceuticals holds Efficiency (Sharpe) Ratio of 0.083, which attests that the entity had a 0.083% return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 3.14% are justified by taking the suggested risk. Use Galmed Pharmaceuticals Risk Adjusted Performance of 0.0688, downside deviation of 11.31, and Market Risk Adjusted Performance of (13.96) to evaluate company specific risk that cannot be diversified away.
At present, Galmed Pharmaceuticals' Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 1.7 M, whereas Total Stockholder Equity is forecasted to decline to about 13.2 M. . At present, Galmed Pharmaceuticals' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.09, whereas Price Earnings To Growth Ratio is forecasted to decline to (0). Galmed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of March 2014 | 200 Day MA 4.1925 | 50 Day MA 4.1858 | Beta 0.798 |
Galmed |
Sharpe Ratio = 0.083
| Best Portfolio | Best Equity | |||
| Good Returns | GLMD | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 37.86 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.14 actual daily | 62 62% of assets have lower returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Galmed Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Galmed Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.2642 | Book Value 33.01 | Enterprise Value -7.7 M | Enterprise Value Ebitda 0.3212 | Shares Float 523.1 K |
Galmed Pharmaceuticals Stock Price History Chart
There are several ways to analyze Galmed Stock price data. The simplest method is using a basic Galmed candlestick price chart, which shows Galmed Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 17, 2024 | 15.1 |
| Lowest Price | November 22, 2024 | 2.75 |
Galmed Pharmaceuticals December 3, 2024 Stock Price Synopsis
Various analyses of Galmed Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Galmed Stock. It can be used to describe the percentage change in the price of Galmed Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Galmed Stock.| Galmed Pharmaceuticals Price Action Indicator | 0.05 | |
| Galmed Pharmaceuticals Price Daily Balance Of Power | 0.23 | |
| Galmed Pharmaceuticals Price Rate Of Daily Change | 1.03 |
Galmed Pharmaceuticals December 3, 2024 Stock Price Analysis
Galmed Stock Price History Data
The price series of Galmed Pharmaceuticals for the period between Wed, Sep 4, 2024 and Tue, Dec 3, 2024 has a statistical range of 12.35 with a coefficient of variation of 49.26. Under current investment horizon, the daily prices are spread out with arithmetic mean of 4.3. The median price for the last 90 days is 3.64. The company completed 1:12 stock split on 30th of August 2024.| Open | High | Low | Close | Volume | ||
12/03/2024 | 2.83 | 3.10 | 2.75 | 2.94 | ||
| 12/02/2024 | 2.83 | 3.10 | 2.75 | 2.94 | 69,126 | |
| 11/29/2024 | 2.78 | 2.94 | 2.78 | 2.86 | 18,415 | |
| 11/27/2024 | 2.90 | 2.91 | 2.71 | 2.86 | 53,993 | |
| 11/26/2024 | 2.93 | 2.93 | 2.74 | 2.87 | 37,084 | |
| 11/25/2024 | 2.75 | 2.92 | 2.68 | 2.87 | 50,504 | |
| 11/22/2024 | 2.81 | 2.82 | 2.75 | 2.75 | 16,696 | |
| 11/21/2024 | 2.94 | 2.94 | 2.75 | 2.80 | 45,426 | |
| 11/20/2024 | 3.05 | 3.05 | 2.85 | 2.96 | 49,537 | |
| 11/19/2024 | 2.86 | 3.01 | 2.85 | 3.00 | 40,135 | |
| 11/18/2024 | 2.96 | 2.98 | 2.84 | 2.94 | 24,002 | |
| 11/15/2024 | 3.03 | 3.12 | 2.88 | 2.93 | 35,545 | |
| 11/14/2024 | 3.00 | 3.13 | 3.00 | 3.10 | 17,588 | |
| 11/13/2024 | 3.08 | 3.08 | 2.93 | 2.99 | 35,714 | |
| 11/12/2024 | 2.99 | 3.18 | 2.86 | 3.02 | 63,175 | |
| 11/11/2024 | 2.89 | 2.96 | 2.73 | 2.88 | 78,346 | |
| 11/08/2024 | 3.10 | 3.11 | 2.81 | 2.97 | 138,900 | |
| 11/07/2024 | 3.03 | 3.23 | 2.97 | 3.08 | 89,940 | |
| 11/06/2024 | 3.27 | 3.45 | 3.04 | 3.10 | 102,038 | |
| 11/05/2024 | 3.24 | 3.38 | 3.24 | 3.37 | 24,241 | |
| 11/04/2024 | 3.19 | 3.57 | 3.15 | 3.24 | 66,505 | |
| 11/01/2024 | 3.34 | 3.38 | 3.10 | 3.24 | 67,596 | |
| 10/31/2024 | 3.51 | 3.55 | 3.04 | 3.34 | 149,141 | |
| 10/30/2024 | 3.56 | 3.90 | 3.43 | 3.50 | 82,535 | |
| 10/29/2024 | 3.87 | 3.94 | 3.57 | 3.66 | 147,052 | |
| 10/28/2024 | 3.97 | 4.16 | 3.90 | 3.90 | 37,989 | |
| 10/25/2024 | 4.00 | 4.14 | 3.93 | 3.93 | 25,829 | |
| 10/24/2024 | 4.37 | 4.68 | 4.00 | 4.03 | 61,929 | |
| 10/23/2024 | 4.79 | 4.79 | 4.18 | 4.54 | 121,669 | |
| 10/22/2024 | 4.68 | 4.81 | 4.37 | 4.81 | 134,333 | |
| 10/21/2024 | 3.90 | 4.70 | 3.80 | 4.68 | 375,660 | |
| 10/18/2024 | 3.41 | 3.83 | 3.41 | 3.80 | 118,089 | |
| 10/17/2024 | 3.68 | 3.68 | 3.40 | 3.46 | 442,902 | |
| 10/16/2024 | 3.84 | 4.03 | 3.51 | 3.64 | 160,399 | |
| 10/15/2024 | 3.68 | 4.15 | 3.67 | 3.92 | 243,859 | |
| 10/14/2024 | 3.75 | 4.00 | 3.60 | 3.67 | 71,951 | |
| 10/11/2024 | 3.75 | 4.24 | 3.67 | 3.85 | 238,325 | |
| 10/10/2024 | 3.83 | 3.95 | 3.76 | 3.82 | 76,116 | |
| 10/09/2024 | 4.10 | 4.10 | 3.82 | 3.91 | 159,926 | |
| 10/08/2024 | 4.03 | 4.28 | 3.84 | 3.98 | 211,123 | |
| 10/07/2024 | 4.22 | 4.49 | 4.11 | 4.11 | 144,393 | |
| 10/04/2024 | 4.64 | 5.04 | 4.04 | 4.20 | 299,345 | |
| 10/03/2024 | 5.05 | 5.20 | 4.68 | 4.73 | 170,644 | |
| 10/02/2024 | 5.72 | 5.72 | 4.91 | 5.04 | 229,273 | |
| 10/01/2024 | 6.85 | 6.87 | 5.68 | 5.82 | 199,230 | |
| 09/30/2024 | 7.03 | 7.50 | 6.76 | 6.86 | 164,736 | |
| 09/27/2024 | 7.06 | 7.76 | 7.03 | 7.09 | 231,758 | |
| 09/26/2024 | 7.11 | 7.56 | 6.67 | 7.33 | 376,459 | |
| 09/25/2024 | 8.37 | 8.49 | 6.60 | 7.09 | 782,335 | |
| 09/24/2024 | 9.76 | 10.00 | 7.80 | 8.05 | 746,796 | |
| 09/23/2024 | 9.79 | 11.19 | 9.04 | 9.35 | 2,282,408 | |
| 09/20/2024 | 9.85 | 12.60 | 8.36 | 9.35 | 15,035,945 | |
| 09/19/2024 | 9.10 | 13.58 | 7.90 | 8.40 | 36,170,018 | |
| 09/18/2024 | 10.61 | 11.12 | 6.56 | 6.90 | 6,218,581 | |
| 09/17/2024 | 5.36 | 23.80 | 5.34 | 15.10 | 98,465,343 | |
| 09/16/2024 | 3.95 | 4.19 | 3.56 | 3.87 | 353,226 | |
| 09/13/2024 | 4.01 | 4.44 | 3.60 | 4.11 | 884,036 | |
| 09/12/2024 | 3.63 | 4.25 | 3.57 | 3.98 | 251,016 | |
| 09/11/2024 | 3.54 | 3.66 | 3.34 | 3.56 | 20,271 | |
| 09/10/2024 | 3.44 | 3.60 | 3.31 | 3.56 | 77,102 | |
| 09/09/2024 | 3.01 | 3.40 | 3.01 | 3.37 | 38,110 |
About Galmed Pharmaceuticals Stock history
Galmed Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Galmed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Galmed Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Galmed Pharmaceuticals stock prices may prove useful in developing a viable investing in Galmed Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 230.8 K | 219.3 K | |
| Net Loss | -25.9 M | -24.6 M |
Galmed Pharmaceuticals Quarterly Net Working Capital |
|
Galmed Pharmaceuticals Stock Technical Analysis
Galmed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Galmed Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Galmed Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Galmed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Galmed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0688 | |||
| Jensen Alpha | 2.9 | |||
| Total Risk Alpha | (2.71) | |||
| Sortino Ratio | 0.2441 | |||
| Treynor Ratio | (13.97) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Galmed Stock analysis
When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |